RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus

Journal of Clinical Microbiology

Volumn 47, Issue 7, 2009, Pages 2136-2141

  Cattani, Paola ^a   Siddu, Alessia ^a   D'Onghia, Sara ^a   Marchetti, Simona ^a   Santangelo, Rosaria ^a   Vellone, Valerio G ^a   Zannoni, Gian Franco ^a   Fadda, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN E7;

ADULT; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENHANCER REGION; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HYBRIDIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS INFECTION; WART VIRUS;

ADULT; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; RNA, VIRAL; VAGINAL SMEARS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 67650066325     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01733-08     Document Type: Article

References (48)

1. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer. J. Natl. Cancer Inst. 87:796-802.
2. Boulet, G. A., C. A. Horvath, S. Berghmans, and J. Bogers. 2008. Human papillomavirus in cervical cancer screening: important role as biomarker. Cancer Epidemiol. Biomarkers Prev. 17:810-817.
3. Bulkmans, N. W., L. Rozendaal, P. J. Snijders, F. J. Voorhorst, A. J. Boeke, G. R. Zandwijken, F. J. van Kemenade, R. H. Verheijen, K. van Groningen, M. E. Boon, H. J. Keuning, M. van Ballegooijen, A. J. van den Brule, and C. J. Meijer. 2004. POBASCAM, a population-based randomised controlled trial for implementation of high risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int. J. Cancer 110:94-101.
4. Castle, P. E., J. Dockter, C. Giachetti, F. A. Garcia, M. K. McCormick, A. L. Mitchell, E. B. Holladay, and D. P. Kolk. 2007. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for the detection of cervical precancer and cancer. Clin. Cancer Res. 13: 2599-2605.
5. Clary, K. M., J. F. Silverman, Y. Liu, C. D. Sturgis, D. M. Grzybicki, L. K. Mahood, and S. S. Raab. 2002. Cytohistologic discrepancies: a means to improve pathology practice and patient outcomes. Am. J. Clin. Pathol. 117: 567-573.
6. Clifford, G. M., J. S. Smith, M. Plummer, N. Munoz, and S. Franceschi. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88:63-73.
7. Cox, T., and J. Cuzick. 2006. HPV DNA testing in cervical cancer screening: from evidence to policies. Gynecol. Oncol. 103:8-11.
8. Cuschieri, K. S., M. J. Whitley, and H. A. Cubie. 2004. Human papillomavirus type specific DNA and RNA persistence-implications for cervical disease progression and monitoring. J. Med. Virol. 73:65-70.
9. Cuschieri, K., and N. Wentzensen. 2008. Human papillomavirus RNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol. Biomarkers Prev. 17:2536-2545.
10. Cuzick, J., C. Clavel, K. U. Petry, C. J. Meijer, H. Hoyer, S. Ratnam, A. Szarewski, P. Birembaut, S. Kulasingam, P. Sasieni, and T. Iftner. 2006. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int. J. Cancer 119:1095-1101.
11. Cuzick, J., M. H. Mayrand, G. Ronco, P. Snijders, and J. Wardle. 2006. Chapter 10: new dimensions in cervical cancer screening. Vaccine 24:S90-S97.
12. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
13. Dunne, E. F., and L. E. Markowitz. 2006. Genital human papillomavirus infection. Clin. Infect. Dis. 43:624-629.
14. Elfgren, K., E. Rylander, T. Radberg, B. Strander, A. Strand, K. Panjanen, I. Sjoberg, W. Ryd, I. Silins, and J. Dillner. 2005. Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence. Am. J. Obstet. Gynecol. 193:650-657.
15. Gravitt, P. E., M. B. Kovacic, R. Herrero, M. Schiffman, C. Bratti, A. Hildesheim, J. Morales, M. Alfaro, M. E. Sherman, S. Wacholder, A. C. Rodriguez, and R. D. Burk. 2007. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int. J. Cancer 121:2787-2793.
16. Hariri, J., and A. ∅ster. 2007. The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix. Int. J. Gynecol. Pathol. 26:223-238.
17. Ho, G. Y., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
18. Kjaer, S. K., A. J. van den Brule, G. Paull, E. I. Svare, M. E. Sherman, B. L. Thomsen, M. Suntum, J. E. Bock, P. A. Poll, and C. J. Meijer. 2002. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325:572.
19. Kraus, I., T. Molden, L. E. Erno, H. Skomedal, F. Karlsen, and B. Hagmar. 2004. Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones. Br. J. Cancer 90:1407-1413.
20. Kraus, I., T. Molden, R. Holm, A. K. Lie, F. Karlsen, G. B. Kristensen, and H. Skomedal. 2006. Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas. J. Clin. Microbiol. 44:1310-1317.
21. Laara, E., N. E. Day, and M. Hakama. 1987. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet i:1247-1249.
22. Lie, A. K., B. Risberg, B. Borge, B. Sandstad, J. Delabie, R. Rimala, M. Onsrud, and S. Thoresen. 2005. DNA-versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol. Oncol. 97:908-915.
23. Manavi, M., G. Hudelist, A. Fink-Retter, D. Gschwantler-Kaulich, K. Pischinger, and K. Czerwenka. 2008. Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women. Int. J. Gynecol. Cancer 18:285-294.
24. Melchers, W., A. van den Brule, J. Walboomers, M. de Bruin, M. Burger, P. Herbrink, C. Meijer, J. Lindeman, and W. Quint. 1989. Increased detection rate of human papillomavirus in cervical scrapes by the polymerase chain reaction as compared to modified FISH and Southern-blot analysis. J. Med. Virol. 27:329-335.
25. Molden, T., I. Kraus, F. Karlsen, H. Skomedal, J. F. Nygård, and B. Hagmar. 2005. Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women 30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol. Biomarkers Prev. 14:367-372.
26. Molden, T., J. F. Nygård, I. Kraus, F. Karlsen, M. Nygård, G. B. Skare, H. Skomedal, S. O. Thoresen, and B. Hagmar. 2005. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL Pap smear. Int. J. Cancer 114:973-976.
27. Molden, T., I. Kraus, F. Karlsen, H. Skomedal, and B. Hagmar. 2006. Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age. Gynecol. Oncol. 100:95-100.
28. Moscicki, A. B., M. Schiffman, S. Kjaer, and L. L. Villa. 2006. Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 24:S42-S51.
29. Munger, K., and P. M. Howley. 2002. Human papillomavirus immortalization and transformation functions. Virus Res. 89:213-228.
30. Munger, K., A. Baldwin, K. M. Edwards, H. Hayakawa, C. L. Nguyen, M. Owens, M. Grace, and K. Huh. 2004. Mechanisms of human papillomavirus- induced oncogenesis. J. Virol. 78:11451-11460.
31. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, C. J. Meijer, et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
32. Nakagawa, S., H. Yoshikawa, T. Yasugi, M. Kimura, K. Kawana, K. Matsumoto, M. Yamada, T. Onda, and Y. Taketani. 2000. Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type. J. Med. Virol. 62:251-258.
33. Plummer, M., M. Schiffman, P. E. Castle, D. Maucort-Boulch, C. M. Wheeler, and ALTS Group. 2007. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis. 195:1582-1589.
34. Quint, W. G., S. R. Pagliusi, N. Lelie, E. M. de Villiers, C. M. Wheeler, et al. 2006. Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J. Clin. Microbiol. 44:571-579.
35. Saiki, R. K., T. L. Bugawan, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1986. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324:63-66.
36. Sasieni, P. D., J. Cuzick, and E. Lynch-Farmery. 1996. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. Br. J. Cancer 73:1001-1005.
37. Scheurer, M. E., G. Tortolero-Lunay, and K. Adler-Storthzz. 2005. Human papillomavirus infection: biology, epidemiology, and prevention. Int. J. Gynecol. Cancer 15:727-746.
38. Schiffman, M., P. E. Castle, J. Jeronimo, A. C. Rodriguez, and S. Wacholder. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907.
39. Shimonovitz, S., A. Hurwitz, M. Dushnik, E. Anteby, T. Geva-Eldar, and S. Yagel. 1994. Developmental regulation of the expression of 72 and 92 kd type IV collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion. Am. J. Obstet. Gynecol. 171:832-838.
40. Sotlar, K., A. Stubner, D. Diemer, S. Menton, M. Menton, K. Dietz, D. Wallwiener, R. Kandolf, and B. Bültmann. 2004. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J. Med. Virol. 74:107-116.
41. Sotlar, K., D. Diemer, A. Dethleffs, Y. Hack, A. Stubner, N. Vollmer, S. Menton, M. Menton, and K. Dietz. 2004. Detection and typing of human papillomavirus by E6 nested multiplex PCR. J. Clin. Microbiol. 42:3176-3184.
42. van den Brule, A. J., C. J. Meijer, V. Bakels, P. Kenemans, and J. M. Walboomers. 1990. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J. Clin. Microbiol. 28:2739-2743.
43. Walboomers, J. M., M. V. Jacobos, M. M. Manos, F. X. Bosh, J. A. Kummer, K. S. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
44. Wentzensen, N., and M. von Knebel Doeberitz. 2007. Biomarkers in cervical cancer screening. Dis. Markers 23:315-330.
45. Woodman, C. B., S. I. Collins, and L. S. Young. 2007. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 7:11-22.
46. Zur Hausen, H. 1996. Papillomavirus infections - a major cause of human cancer. Biochim. Biophys. Acta 1288:F55-F78.
47. Zur Hausen, H. 2000. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:690-698.
48. Zur Hausen, H. 2002. Papillomavirus and cancer: from basic studies to clinical application. Nat. Rev. 2:342-350.